-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of the cost of borrowed funds accounted for as interest expense.
-
Summary
-
Inhibitor Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q1 2014 to Q4 2022.
- Inhibitor Therapeutics, Inc. Interest Expense for the quarter ending December 31, 2022 was $3.36K.
- Inhibitor Therapeutics, Inc. Interest Expense for the twelve months ending December 31, 2022 was $23.2K.
- Inhibitor Therapeutics, Inc. annual Interest Expense for 2022 was $23.2K, a 56.6% increase from 2021.
- Inhibitor Therapeutics, Inc. annual Interest Expense for 2021 was $14.8K.
- Inhibitor Therapeutics, Inc. annual Interest Expense for 2014 was $37.5K, a 1849% increase from 2013.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)